Open the mobile version, with barcode scanning
Class II Ongoing

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

Why: Failed Dissolution Specifications

Company
Eugia US LLC
East Windsor, NJ, United States
Reported
Mar 13, 2024
Recall started
Feb 20, 2024
Where sold
OH, TN, LA, MS
Amount
10,080 vials
Full product description
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
Lots / codes affected
Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.